Dopaminergic medication and deep brain stimulation exert a shared therapeutic modulation of cortex-subthalamic nucleus network activity in Parkinson’s disease, through a suppression of high beta synchrony mediated by the hyperdirect pathway.
- Thomas S. Binns
- Richard M. Köhler
- Wolf-Julian Neumann
